Sai Parenteral's — 360° view

Sai Parenteral's, a company in the Pharmaceuticals industry, reported revenue of ₹195 crore and net profit of ₹11 crore for the September 2026 quarter.

Sai Parenteral's (NSE: SAIPARENT) closed at ₹492.30 on 20 Nov 2026. Its market capitalisation is ₹2,175 crore and it trades at 87.2 times earnings.

Share price
₹492.30 (20 Nov 2026)
Market cap
₹2,175 Cr (20 Nov 2026)
P/E
87.24 (20 Nov 2026)
Revenue
₹195 Cr (September 2026 quarter)
Net profit
₹11 Cr (September 2026 quarter)
ROCE
5.28% (FY26)
ROE
4.88% (FY26)
Book value
₹112 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹706.00 / ₹400.00 (20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: SAIPARENT

Incorporated in 2001, Sai Parenteral's Ltd. is a diversified pharmaceutical formulations company with expertise in research, development, and manufacturing.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.